ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 178 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,799 | -35.8% | 36,473 | +0.2% | 0.00% | – |
| Q2 2023 | $180,378 | +0.4% | 36,402 | -0.1% | 0.00% | – |
| Q1 2023 | $179,620 | +80.5% | 36,433 | +130.0% | 0.00% | – |
| Q4 2022 | $99,539 | -41.8% | 15,837 | -50.0% | 0.00% | – |
| Q3 2022 | $171,171 | -7.0% | 31,676 | +97.1% | 0.00% | – |
| Q2 2022 | $184,000 | +28.7% | 16,073 | +2.7% | 0.00% | – |
| Q1 2022 | $143,000 | -28.5% | 15,647 | +100.7% | 0.00% | – |
| Q3 2021 | $200,000 | – | 7,795 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |